Myotonic Dystrophy Type 2 Latest Advances

Find the Latest Research About Myotonic Dystrophy Type 2

Last Updated: 11/08/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6965 publications

Exploring the gut microbiome in children and young adults with myotonic dystrophy type 1.

Exploring the gut microbiome in children and young adults with myotonic dystrophy type 1.

Journal: Journal of neuromuscular diseases
Published: October 26, 2026

Cas9 nickase-mediated contraction of CAG/CTG repeats is associated with phenotypic improvements in a Huntington's disease mouse model.

Cas9 nickase-mediated contraction of CAG/CTG repeats is associated with phenotypic improvements in a Huntington's disease mouse model.

Journal: Science translational medicine
Published: October 22, 2026

The cognitive-behavioral missing link in myotonic dystrophy type 1: Rethinking social cognition assessment.

The cognitive-behavioral missing link in myotonic dystrophy type 1: Rethinking social cognition assessment.

Journal: Journal of neuromuscular diseases
Published: October 15, 2026

Three-Year Longitudinal Analysis of Splicing Changes in Myotonic Dystrophy Type 1.

Three-Year Longitudinal Analysis of Splicing Changes in Myotonic Dystrophy Type 1.

Journal: bioRxiv : the preprint server for biology
Published: October 10, 2026

Antisense Oligonucleotide-Mediated Degradation of Toxic RNA in Myotonic Dystrophy Type 1.

Antisense Oligonucleotide-Mediated Degradation of Toxic RNA in Myotonic Dystrophy Type 1.

Journal: Methods in molecular biology (Clifton, N.J.)
Published: September 30, 2026

A mouse model of myotonic dystrophy type 1 exhibits pain-like behavior and peripheral nociceptor hyperexcitability.

A mouse model of myotonic dystrophy type 1 exhibits pain-like behavior and peripheral nociceptor hyperexcitability.

Journal: bioRxiv : the preprint server for biology
Published: September 24, 2026

Myotonic dystrophy type 1 - updates on mechanisms of multisystemic manifestations, genetically targeted therapeutics, and preparing for a postapproval world.

Myotonic dystrophy type 1 - updates on mechanisms of multisystemic manifestations, genetically targeted therapeutics, and preparing for a postapproval world.

Journal: Current opinion in neurology
Published: August 22, 2026

Myotonic dystrophy type 1 as a cancer predisposition syndrome: A case report of quadruple primary malignancies with review of the literature.

Myotonic dystrophy type 1 as a cancer predisposition syndrome: A case report of quadruple primary malignancies with review of the literature.

Journal: Gynecologic oncology reports
Published: August 20, 2026

A Reassuring ECG Is Not Enough in Myotonic Dystrophy Type 1: A Systematic Review and Meta-analysis.

A Reassuring ECG Is Not Enough in Myotonic Dystrophy Type 1: A Systematic Review and Meta-analysis.

Journal: Indian pacing and electrophysiology journal
Published: August 19, 2026

Sympathetic neurons' contribution to arrhythmias in a hiPSC-based myotonic dystrophy type 1 microphysiological system.

Sympathetic neurons' contribution to arrhythmias in a hiPSC-based myotonic dystrophy type 1 microphysiological system.

Journal: Clinical and translational medicine
Published: August 10, 2026

Total energy expenditure assessed by doubly labeled water in patients with myotonic dystrophy type 1: Associations with body composition and functional status.

Total energy expenditure assessed by doubly labeled water in patients with myotonic dystrophy type 1: Associations with body composition and functional status.

Journal: Journal of neuromuscular diseases
Published: August 05, 2026

Structural changes in the retinal layers of patients with Steinert disease.

Structural changes in the retinal layers of patients with Steinert disease.

Journal: Frontiers in ophthalmology
Published: August 05, 2026
Showing 1-12 of 6,965

Last Updated: 11/08/2026